1Mudher A, Lovestone S. Alzheimer's disease-do tauists and baptists finally shake hands? TINS, 2002, 25:22-26
2Walsh DM, Klyubin L, Fedeeva JV, et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature, 2002, 416:535-540
3Capsoni S, Ugolini G, Comparini A, et al. Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Pro Nal Acad Sci, 2000, 97:6826-6831
4Salehi A, Delcroix JD, Mobley WC. Traffic at the intersection of neurotrophic factor signaling and neurodegencration. TINS, 2003, 26:73-76
5Carroll RC, Zukin S. NMDA-receptor trafficking and targeting: implications for synaptic transmission and plasticity.Trends in Neuroscience, 2002, 25:571-577
6Akama KT, McEwen BS. Estrogen stimulates postsynaptic density-95 rapid protein synthesis via the Akt/protein kinase B pathway. J Neurosci, 2003, 23:2333-2337
7Heininger K. A unifying hypothesis of Alzheimer's disease Ⅳ causation and sequence of events. Rew Neurosci, 2000,11:213-215
8Mesulam M, Guillozet A, Shaw P, et al. Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain. Neurobiol Dis, 2002, 9:88-93
9Lynch G. Memory enhancement: the search for mechanismbased drugs. Nat Neurosci, 2002, 5(suppl):1035-1038
10Nordberg A. New targets for Alzheimer therapy. In: Iqbal K,Winblad B, eds. AD and related disorders: research advances. Bucharest Romania: Ana Aslan, 2003.500-512
